Impact on pregnancy outcomes when changing diagnostic criteria for gestational diabetes in Swede
Not Applicable
- Conditions
- Gestational diabetes mellitusPregnancy and Childbirth
- Registration Number
- ISRCTN41918550
- Lead Sponsor
- Region Örebro County
- Brief Summary
2019 Protocol article in https://www.ncbi.nlm.nih.gov/pubmed/31675922 protocol (added 06/11/2019) 2024 Results article in https://doi.org/10.1371/journal.pmed.1004420 (added 09/07/2024)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Ongoing
- Sex
- Female
- Target Recruitment
- 71500
Inclusion Criteria
All pregnant women in the participating hospitals and their uptake regions.
Exclusion Criteria
Preexisting diabetes mellitus.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method arge for Gestational Age (LGA) is measured as the weight of the baby will be measured at time of birth.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
How do revised HbA1c thresholds in ISRCTN41918550 impact molecular pathways of insulin resistance in gestational diabetes?
What comparative effectiveness data exists between Sweden's new GDM diagnostic criteria and standard oral glucose tolerance testing?
Which biomarkers correlate with adverse pregnancy outcomes in ISRCTN41918550's gestational diabetes diagnostic trial?
What adverse event profiles emerged from Sweden's stepped wedge GDM diagnostic criteria implementation in 2017-2025?
How do ISRCTN41918550's findings influence global diagnostic guidelines for gestational diabetes mellitus?